We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Challenge to Reduce Sexually Transmitted Disease Infections Spurs Growth in IVD Sector

By LabMedica International staff writers
Posted on 20 Dec 2015
Print article
Nearly one out of every five dollars earned in infectious disease testing is from a test for sexually transmitted infections (STIs) or women’s health test, according to a new healthcare market research report.

In its new analysis, “The World Market for Infectious Disease Testing,” Kalorama Information (New York, NY, USA) reported that responding to resilient and rebounding rates of STIs and the increasing specialization in medicine to optimally treat female patients and conditions, many in the IVD industry have prioritized assay menus in those areas across platforms, foremost in molecular diagnostics. Still, a diverse range of IVD products are used to for screening and assessment, including cultures, laboratory immunoassays, rapid immunoassays, molecular assays, and high-throughput blood screening assays.

“With consistent national reporting in the United States, it has become apparent that STIs have rebounded from reported historical lows and been resilient to eradication goals,” said Emil Salazar, Kalorama IVD analyst.

Within IVD, infectious disease tests for STIs and women’s health typically do not include diagnostics for HIV or viral hepatitis, which independently represent multi-billion-dollar markets. The most significant pathogens in STI and women’s health testing include Chlamydia (CT), gonorrhea (NG), syphilis, ToRCH panel pathogens, and human papillomavirus (HPV). The infections are highly impactful to community health, maternal health, and prenatal and neonatal health.

Chlamydia has been on the rise since reporting began in the US. Gonorrhea declined nearly 75% between 1975–1997, but thereafter remained roughly constant through 2009 before rising slightly every year through 2012. Syphilis , after declining nearly 90% between 1990-2000, reached its lowest rate in the US since reporting began in 1941. The dramatic decline of syphilis and the regional concentration of the disease lead the Surgeon General to release a national eradication plan in 1999, updated in 2006. However, syphilis rate subsequently increased each year from 2001 to 2009 and jumped another 22% between 2011–2013.

In some cases, the observed increases in STIs may be a result of improved screening and reporting efforts rather than an actual groundswell in infections. Among sexually active US women aged 16–24 years with commercial insurance plans, Chlamydia screening nearly doubled between 2001-2012 to 45%. Increased Chlamydia screening has also impacted gonorrhea reporting as multiplex CT/NG testing is highly common.

“While truly rising STI incidence in the US is debatable, the above trends are nonetheless positive for the IVD industry since STI screening is becoming more commonplace in healthcare given an ongoing emphasis upon preventative care and improving national insurance coverage,” said Salazar.

Related Links:

Kalorama Information 
World Market for Infectious Disease Testing, report


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Researchers have found a way to spot the debilitating disease Alzheimer\'s before it develops into dementia (Photo courtesy of 123RF)

Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia

Alzheimer’s disease is well known for its slow development over many years, which typically leads to treatment interventions only after the disease has advanced to stages where it may be nearly impossible... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more